Skip to content
Cardiovascular healthTrial meta-analysis3 min read

Diabetes and hypertension self-care apps lowered HbA1c and blood pressure in 27 trials

MoveVitals Editorial Collective · Study published · Reading updated

Original paper:Effectiveness of Mobile App-Assisted Self-Care Interventions for Improving Patient Outcomes in Type 2 Diabetes and/or Hypertension: Systematic Review and Meta-Analysis of Randomized Controlled Trials. · JMIR mHealth and uHealth · 2020 · Original paper ↗

Key takeaway

Pooling 27 randomised trials, mobile app-assisted self-care was linked to lower HbA1c (SMD -0.44, 95% CI -0.59 to -0.29) and small reductions in systolic and diastolic blood pressure (both SMD -0.17). Effects are given in standardised units, and the abstract does not report heterogeneity.

Study design

Trial meta-analysis

Reading basis

Published abstract

Reading focus

Design & applicability

The research question

Mobile apps are promising tools for supporting self-care in type 2 diabetes and hypertension, but evidence needs strengthening. The authors tested whether app-assisted self-care improves patient outcomes, and which app features go with better results.

Who and how

Systematic review and meta-analysis of randomised controlled trials, following Cochrane Collaboration guidelines. MEDLINE, Cochrane Library, EMBASE and CINAHL Plus were searched for studies published between January 2007 and January 2019. Primary outcomes were change in HbA1c, systolic blood pressure (SBP) and diastolic blood pressure (DBP). Other outcomes were secondary. Outcomes reported in at least two trials were meta-analyzed, otherwise results were synthesised narratively. 27 trials were included.

What it found

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    HbA1c fell significantly with app-assisted self-care (standardized mean difference [SMD] -0.44; 95% CI -0.59 to -0.29; P < .001).
  2. 2
    Systolic blood pressure fell (SMD -0.17; 95% CI -0.31 to -0.03; P = .02), as did diastolic blood pressure (SMD -0.17; 95% CI -0.30 to -0.03; P = .02).
  3. 3
    Of the 8 objective secondary outcomes meta-analyzed, fasting blood glucose and waist circumference fell significantly. 42 other secondary outcomes were narratively synthesised, with mixed results.
  4. 4
    Features linked to better self-management included glucose, blood pressure and medication monitoring, contact with providers, automated feedback, personalized goals, reminders, education and data visualization.

Limits & uncertainty

  1. 1
    Effects are in standardised mean differences, which are hard to translate into real HbA1c or mm Hg changes, and the blood pressure effect is small.
  2. 2
    The abstract reports nothing about trial quality or heterogeneity between trials, so the confidence in these estimates is unclear.
  3. 3
    Feature findings come from subgroup analyses, which are weaker evidence about what makes apps work.
  4. 4
    Evidence for behavioural, knowledge and psychosocial outcomes is still scarce, as the authors state. This reading is based on the abstract only.

What to take from it

For people already managing type 2 diabetes or hypertension, a well-designed self-care app, especially one with feedback and contact with the care team, may help a little. It does not replace medical care and it is not a basis for changing medication. Discuss which tools to use with your clinician.

Reading your own data

If you have a glucometer or blood pressure cuff, logging readings in an app at consistent times and sharing the trend with your clinician matches the features these trials found useful. Compare readings with the same device and routine, and look at the overall trend.

How to read this evidence

Pooling trials can improve precision, but compare populations, controls, bias and uncertainty. Network rankings include indirect evidence and do not identify a universal best treatment.

Authors’ structured abstract English

The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.

Background

Mobile app-assisted self-care interventions are emerging promising tools to support self-care of patients with chronic diseases such as type 2 diabetes and hypertension. The effectiveness of such interventions requires further exploration for more supporting evidence.

Objective

A systematic review and meta-analysis of randomized controlled trials (RCTs) were conducted to examine the effectiveness of mobile app-assisted self-care interventions developed for type 2 diabetes and/or hypertension in improving patient outcomes.

Methods

We followed the Cochrane Collaboration guidelines and searched MEDLINE, Cochrane Library, EMBASE, and CINAHL Plus for relevant studies published between January 2007 and January 2019. Primary outcomes included changes in hemoglobin A_(1c) (HbA_(1c)) levels, systolic blood pressure (SBP), and diastolic blood pressure (DBP). Changes in other clinical-, behavioral-, knowledge-, and psychosocial-related outcomes were included as secondary outcomes. Primary outcomes and objective secondary outcomes that were reported in at least two trials were meta-analyzed; otherwise, a narrative synthesis was used for data analysis.

Results

A total of 27 trials were identified and analyzed. For primary outcomes, the use of mobile app-assisted self-care interventions was associated with significant reductions in HbA_(1c) levels (standardized mean difference [SMD] -0.44, 95% CI -0.59 to -0.29; P<.001), SBP (SMD -0.17, 95% CI -0.31 to -0.03, P=.02), and DBP (SMD -0.17, 95% CI -0.30 to -0.03, P=.02). Subgroup analyses for primary outcomes showed that several intervention features were supportive of self-management, including blood glucose, blood pressure, and medication monitoring, communication with health care providers, automated feedback, personalized goal setting, reminders, education materials, and data visualization. In addition, 8 objective secondary outcomes were meta-analyzed, which showed that the interventions had significant lowering effects on fasting blood glucose levels and waist circumference. A total of 42 secondary outcomes were narratively synthesized, and mixed results were found.

Conclusions

Mobile app-assisted self-care interventions can be effective tools for managing blood glucose and blood pressure, likely because their use facilitates remote management of health issues and data, provision of personalized self-care recommendations, patient-care provider communication, and decision making. More studies are required to further determine which combinations of intervention features are most effective in improving the control of the diseases. Moreover, evidence regarding the effects of these interventions on the behavioral, knowledge, and psychosocial outcomes of patients is still scarce, which warrants further examination.

Sources & attribution

Effectiveness of Mobile App-Assisted Self-Care Interventions for Improving Patient Outcomes in Type 2 Diabetes and/or Hypertension: Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Liu K, Xie Z, Or CK.

JMIR mHealth and uHealth · 2020-08-04

DOI: 10.2196/15779 ↗PubMed · 32459654 ↗Europe PMC · Recorded licence: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

MoveVitals editorial interpretation · educational content · no individual clinical review recorded

Sources checked 2026-11-01

Practical guides

Read in context

·Observational meta-analysis

Disrupted daily rest-activity rhythm is linked to higher mortality in 109,365 people

Across seven observational studies with 109,365 participants, a weaker day-night activity contrast (lower relative amplitude) was associated with higher cardiovascular mortality (hazard ratio [HR] 1.50, 95% CI 1.13 to 1.98) and all-cause mortality (HR 1.46, 95% CI 1.27 to 1.68). The evidence base is small and observational, so it cannot show that improving the rhythm lowers risk, and illness may itself disturb the rhythm.

Journal of the American Heart Association

In-depth explainersRead study →
·Trial meta-analysis

Five exercise types lowered resting blood pressure, isometric training the most

Pooling 270 randomised trials with 15,827 participants, aerobic, resistance, combined, interval and isometric training all lowered resting blood pressure compared with non-intervention controls (P<0.001 for each), with the largest fall for isometric training: 8.24 mm Hg systolic and 4.00 mm Hg diastolic. The ranking between modes is partly indirect and the trials differ, so it is not a personal prescription.

British Journal of Sports Medicine

In-depth explainersRead study →
·Randomised trial

A salt substitute lowered stroke, major cardiovascular events and death in rural China

In 20,995 people in 600 rural Chinese villages who had a history of stroke or were 60 or older with high blood pressure, a salt substitute (75% sodium chloride, 25% potassium chloride) lowered the stroke rate versus regular salt over a mean 4.74 years: 29.14 versus 33.65 events per 1000 person-years (rate ratio 0.86, 95% CI 0.77 to 0.96; P = 0.006). Death was also lower (rate ratio 0.88) and serious hyperkalemia events were not significantly higher, but the trial was open-label and set in rural China.

The New England Journal of Medicine

In-depth explainersRead study →
·Validation study/review

Apple Watch irregular-pulse alerts were rare; 34% of those tested had atrial fibrillation

Among 419,297 Apple Watch users with no known atrial fibrillation (AF), 0.52% received an irregular-pulse alert, and 34% of the 450 who returned a usable ECG patch had AF (97.5% CI 29 to 39). Alerts that coincided with patch recording matched AF with a positive predictive value of 0.84 (95% CI 0.76 to 0.92), but only 20.8% of alerted people returned a patch and nobody without an alert was monitored, so a quiet watch does not rule AF out.

The New England Journal of Medicine

In-depth explainersRead study →
Cardiovascular health →